Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy
The combination of glucagon receptor activation with appropriate resistance training and protein intake creates optimal conditions for losing fat while maintaining muscle
In a survey of 2,173 patients who discontinued the use of GLP-1 drugs, a majority of the patients identified two main areas of concern: the GI-related discomfort or the negativity associated with injections: In a separate survey published in March 2026, of 1,536 Canadians and 1,012 Americans, Leger Healthcare market research reported a number of key findings related to GLP-1 use and intentions across North America: 11% of American adults and 8% of Canadian adults are currently taking a GLP-1 prescription Extrapolated, this suggests that 28M+ American adults and 3M+ Canadian adults are currently using GLP-1 prescriptions 12% of Americans and 6% of Canadians are interested in taking a GLP-1 prescription 71% of Americans and 58% of Canadians cite weight loss as a primary reason for their interest in GLP-1 drugs Given that nearly two-thirds of GLP-1 customers focused on weight loss tend to discontinue use of the drugs within the first year, Lexaria knew that our attempts to improve the patient experience could provide a profoundly positive business case
You will have to continue with these B12 shots and take high doses of B12 supplements after that
Studies suggest that ALC supplements in particular may be effective at helping to countering the fatigue experienced by patients with conditions like chronic fatigue syndrome and possibly multiple sclerosis
/assets/images/provider/photos/2802570.png)
